Toronto, Canada · Founded 2023 · Privately Held (backing)
Developer of an artificial intelligence drug discovery platform designed to offer targeted therapies for biologically defined patient sub-populations. Biossil is based in Toronto, Canada and was founded in 2023. It has raised $12.4 million.
Last price · $/share
—
Implied valuation
—
Total raised
$12.4M
Last round
—
Cap table — not yet on record
Biossil's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biossil with a free account
·Watch Biossil: the Monday email on marks, rounds and moves
